Kalydeco is a medication commonly used to help people with cystic fibrosis improve lung function and overall breathing health. It works by targeting specific gene mutations linked to the condition, helping the body produce better airflow and mucus control. Many patients experience improved respiratory performance, fewer infections, and better daily comfort after using this treatment under medical supervision.